MRC Centre for Neuropsychiatric Genetics and Genomics - Cardiff University
Chronic traumatic encephalopathy: quantifying risk and clarifying pathogenesis
Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis
i3–IRG - School of Medicine - Cardiff University
Pharmaceuticals | Free Full-Text | B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders | HTML
Survival and cause of death in multiple sclerosis: a prospective population-based study
Creutzfeldt–Jacob disease: new directions in diagnosis and therapeutics
Cerebrospinal Fluid Complement System Biomarkers in Demyelinating Disease. Wioleta M. Zelek1, Dina Fathalla1, Angharad Morgan1,
B cell treatments for multiple sclerosis
Professor Paul Morgan - People - Cardiff University
Complement regulator factor H as a serum biomarker of multiple sclerosis disease state
Professor Neil Robertson - People - Cardiff University
Validity of patient-derived disability and clinical data in multiple sclerosis
Complement, a target for therapy in inflammatory and degenerative diseases | Nature Reviews Drug Discovery
Neil P Robertson's research works | Cardiff University, Cardiff (CU) and other places
Postgraduate study - School of Healthcare Sciences - Cardiff University
Pediatric Neurology Briefs | Vol 27, No 03 | March 2013
Modelling the natural history of primary progressive multiple sclerosis
Seasonal variation in multiple sclerosis relapse
Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E
Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E
Physiotherapy and related activities in multiple sclerosis
Multiple sclerosis: early indicators of disease and assessing future risk
